Global Plasma Protein Therapeutics Market By Product (Immunoglobulin, Albumin, Plasma Derived Clotting Factor, Fibrinogen, Others), By Application (Hemophilia, Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura (ITP), Others), By End User (Hospitals, Research Laboratories and Institutions, Stand-Alone Blood Banks, Others), By Region, Competition Forecast & Opportunities, 2027

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Global plasma protein therapeutics market is projected to show robust growth in the forecast period, 2023-2027, on the account of increased food and drug administration (FDA) approvals for the plasma products across multiple indications. Along with such major factors, increased research and development in the field of developing drugs and treatment procedures out of plasma proteins is driving the growth of the global plasma protein therapeutics market.

Moreover, the market is experiencing a surge in the demand of advanced therapeutic remedies being developed from the plasma protein because of its effective advantages, thereby driving the growth of the market. Furthermore, the government aids toward the advancing healthcare industry and the favorable reimbursement policies by the health policy investment companies which is driving the growth of the market. With the consistent technological advancements towards the extraction and separation of plasma, devising treatment therapeutics out of plasma protein and manufacturing of advanced methods for the administration of these therapeutic treatments is driving the global plasma protein therapeutics market in the upcoming five years.

The global plasma protein therapeutics market is segmented by product, application, end user, competitional landscapes, and regional distribution. Based on product, the market is further fragmented into immunoglobulin, albumin, plasma derived clotting factor, fibrinogen, and others. Immunoglobulin is anticipated to hold the largest market share in the next five years, owing to approval of therapeutic across multiple indications from the FDA, and ease of administration along with the treatment cost. Immunoglobulins are the antibodies that are present in the blood. In case of any infection, or disease manifestation, the human immune system is designed to generate antibodies against the pathogens/ antigens/ stimulant.

These antibodies avail the ability to fight off the infection by counter-attacking the antigens infecting the body. After the infection subsides, the antibodies are stored as memory cells in the human immune system. These antibodies are now called as immunogens /immunoglobulins. These immunoglobulins are utilized by the body to fight the infection in case of re-attack or any later attack. Plasma protein therapeutic procedure extracts these antibodies that are then used as treatment therapeutics for other patients too. Best example being presented in the current treatments of the COVID-19 patients.

Companies holding major shares of the global plasma protein therapeutics market include CSL Behring LLC, Octapharma AG, Grifols S.A., Shire Plc, Bayer AG, Biotest AG, Kedrion S.P.A., China Biologics Products Holdings, Inc., Takeda Pharmaceutical Company Ltd., Baxter International Ltd., Bio Products Laboratory Ltd., ADMA Biologics, Inc., Pfizer Inc., Ferring BV, and HEMA Biologics LLC, among others.

Objective of the Study:

  • To analyze the historical growth in the market size of the global plasma protein therapeutics market from 2017 to 2021.
  • To estimate and forecast the market size of the global plasma protein therapeutics market from 2022 to 2027 and growth rate until 2027. 
  • To classify and forecast global plasma protein therapeutics market based on product, application, end user, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global plasma protein therapeutics market.
  • To identify drivers and challenges for global plasma protein therapeutics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global plasma protein therapeutics market.
  • To identify and analyze the profile of leading players operating in global plasma protein therapeutics market.
  • To identify key sustainable strategies adopted by market players in global plasma protein therapeutics market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global plasma protein therapeutics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, service providers and other stakeholders
  • Distributers and suppliers of products and other stakeholders
  • Organizations, forums, and alliances related to plasma protein therapeutics market  
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered
  • Product
  • Application
  • End User

Regional Scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa

Key Companies Profiled

CSL Behring LLC, Octapharma AG, Grifols S.A., Shire Plc, Bayer AG, Biotest AG, Kedrion S.P.A., China Biologics Products Holdings, Inc., Takeda Pharmaceutical Company Ltd., Baxter International Ltd., Bio Products Laboratory Ltd., ADMA Biologics, Inc., Pfizer Inc., Ferring BV, and HEMA Biologics LLC.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global plasma protein therapeutics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Global Plasma Protein Therapeutics Market, By Product:
    • Immunoglobulin
    • Albumin
    • Plasma Derived Clotting Factor
    • Fibrinogen
    • Others
  • Global Plasma Protein Therapeutics Market, By Application:
    • Hemophilia
    • Primary Immunodeficiency Disorder (PID)
    • Idiopathic Thrombocytopenic Purpura (ITP)
    • Others
  • Global Plasma Protein Therapeutics Market, By End User:
    • Hospitals
    • Research Laboratories and Institutions
    • Stand-Alone Blood Banks
    • Others
  • Global Plasma Protein Therapeutics Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global plasma protein therapeutics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Plasma Protein Therapeutics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Plasma Protein Therapeutics Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Plasma Protein Therapeutics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Immunoglobulin, Albumin, Plasma Derived Clotting Factor, Fibrinogen, Others)

6.2.2.     By Application (Hemophilia, Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura (ITP), Others)

6.2.3.     By End User (Hospitals, Research Laboratories and Institutions, Stand-Alone Blood Banks, Others)

6.2.4.     By Company (2021)

6.2.5.     By Region

6.3.  Product Market Map

7.    Asia-Pacific Plasma Protein Therapeutics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Application

7.2.3.     By End User

7.2.4.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Plasma Protein Therapeutics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Application

7.3.1.2.3.             By End User

7.3.2.     India Plasma Protein Therapeutics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Application

7.3.2.2.3.             By End User

7.3.3.     Japan Plasma Protein Therapeutics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Application

7.3.3.2.3.             By End User

7.3.4.     South Korea Plasma Protein Therapeutics Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product

7.3.4.2.2.             By Application

7.3.4.2.3.             By End User

7.3.5.     Australia Plasma Protein Therapeutics Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product

7.3.5.2.2.             By Application

7.3.5.2.3.             By End User

8.    Europe Plasma Protein Therapeutics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Application

8.2.3.     By End User

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Plasma Protein Therapeutics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Application

8.3.1.2.3.             By End User

8.3.2.     Germany Plasma Protein Therapeutics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Application

8.3.2.2.3.             By End User

8.3.3.     United Kingdom Plasma Protein Therapeutics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Application

8.3.3.2.3.             By End User

8.3.4.     Italy Plasma Protein Therapeutics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Application

8.3.4.2.3.             By End User

8.3.5.     Spain Plasma Protein Therapeutics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Application

8.3.5.2.3.             By End User

9.    North America Plasma Protein Therapeutics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Application

9.2.3.     By End User

9.2.4.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Plasma Protein Therapeutics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Application

9.3.1.2.3.             By End User

9.3.2.     Mexico Plasma Protein Therapeutics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Application

9.3.2.2.3.             By End User

9.3.3.     Canada Plasma Protein Therapeutics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Application

9.3.3.2.3.             By End User

10.  South America Plasma Protein Therapeutics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Application

10.2.3.  By End User

10.2.4.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Plasma Protein Therapeutics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Application

10.3.1.2.3.           By End User

10.3.2.  Argentina Plasma Protein Therapeutics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Application

10.3.2.2.3.           By End User

10.3.3.  Colombia Plasma Protein Therapeutics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Application

10.3.3.2.3.           By End User

11.  Middle East and Africa Plasma Protein Therapeutics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product

11.2.2.  By Application

11.2.3.  By End User

11.2.4.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Plasma Protein Therapeutics Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Product

11.3.1.2.2.           By Application

11.3.1.2.3.           By End User

11.3.2.  Saudi Arabia Plasma Protein Therapeutics Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Product

11.3.2.2.2.           By Application

11.3.2.2.3.           By End User

11.3.3.  UAE Plasma Protein Therapeutics Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Product

11.3.3.2.2.           By Application

11.3.3.2.3.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Players Profiled

14.2.1.  CSL Behring LLC

14.2.2.  Octapharma AG

14.2.3.  Grifols S.A.

14.2.4.  Shire Plc

14.2.5.  Bayer AG

14.2.6.  Biotest AG

14.2.7.  Kedrion S.P.A.

14.2.8.  China Biologics Products Holdings, Inc.

14.2.9.  Takeda Pharmaceutical Company Ltd.

14.2.10.                Baxter International Ltd.

14.2.11.                Bio Products Laboratory Ltd.

14.2.12.                ADMA Biologics, Inc.

14.2.13.                Pfizer Inc.

14.2.14.                Ferring BV

14.2.15.                HEMA Biologics LLC

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Increased FDA approvals, increased research and development in the field of developing drugs and treatment procedures out of plasma proteins are driving the growth of the global plasma protein therapeutics market in the forecast years, 2023-2027.

down-arrow

CSL Behring LLC, Octapharma AG, Grifols S.A., Shire Plc, Bayer AG, Biotest AG, among others are leading the global plasma protein therapeutics market in the forecast period, 2023-2027.

down-arrow

The global plasma protein therapeutics market analysis was analyzed for the five historical years from 2017 to 2020. Keeping the base year 2020 as the margin, the estimation for the year 2022 was made and further market growth is predicted for the forecast years, 2023 to 2027.

down-arrow

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Plasma Protein Therapeutics Market to Grow with Increasing Targeted Diseases During the Forecast Period

May, 2021

Rapidly advancing medicinal projects are driving the growth in the global plasma protein therapeutics market in the forecast period.

Why Choose Us